[Effect of melipramine on the development of an experimental depressive syndrome in rats, caused by systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
Krupina
N A
NA
Orlova
I N
IN
Kryzhanovskiĭ
G N
GN
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects; D003866:Depressive Disorder / Q000139:chemically induced / Q000517:prevention & control*; D004327:Drinking Behavior / Q000187:drug effects; D007099:Imipramine / Q000494:pharmacology*; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar
D000929:Antidepressive Agents, Tricyclic; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D007099:Imipramine
Vliianie melipramina na razvitie éksperimental'nogo depressivnogo sindroma u krys, vyzvannogo sistemym vvedeniem 1-metil-4-fenil-1,2,3,6-tetragidropiridina (MFTP).